Upgrade to SI Premium - Free Trial

Jefferies Remains Sidelined on Thermo Fisher Scientific (TMO) Following Announced Acquisition of PTHN

May 16, 2017 7:25 AM
Jefferies reiterated a Hold rating and $175.00 price target on Thermo Fisher Scientific (NYSE: TMO) following the company's announced move ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Mergers and Acquisitions

Next Articles